PIND's goal is an integrated, interdisciplinary approach to the study of neurodegenerative diseases and their mechanisms, with the aim of transforming cutting - edge science into novel therapies and diagnostics that directly benefit individuals
affected by neurodegenerative diseases.
Study co-author Marius Wernig, a postdoctoral biologist at M.I.T., reports in Proceedings of the National Academy of Sciences USA, that this is the first time scientists have successfully manipulated such cells to integrate into brain tissue and reverse damage
caused by a neurodegenerative disease.
Studies of PQQ have shown it can optimize the health of the entire central nervous system, reverse cognitive impairment, improve memory, help in stroke recovery, slow the damage
caused by neurodegenerative disease and help protect the brain from toxicity, such as from mercury.
Langston says replacing tissue in the brain
damaged by neurodegenerative disease, such as Alzheimer's or amyotrophic lateral sclerosis — Lou Gehrig's disease — is currently beyond our capacity.